Ketamine-Assisted Psychotherapy (KAP) for Treatment-Resistant Depression

Therapy Topics • March 18, 2026

SUMMARYKetamine-Assisted Psychotherapy (KAP) combines a medically supervised ketamine experience with structured psychotherapy to treat depression, burnout, and complex trauma that haven’t responded to conventional approaches. It works by temporarily quieting the brain’s default mode network — the mental loop generator keeping you locked in self-criticism and rumination — and opening a neuroplasticity window for genuine psychological change. The medicine is the opening. The integration work is where healing actually happens.

TABLE OF CONTENTS

1. She’d Tried Everything, and Nothing Had Touched It
2. What Is Ketamine-Assisted Psychotherapy?
3. The Neuroscience: What Ketamine Actually Does in the Brain
4. How Treatment-Resistant Depression Shows Up in Driven Women
5. KAP and Relational Trauma: The Connection Most People Miss
6. The Both/And Reframe: Surrendering Control to Reclaim Yourself
7. The Hidden Cost of Waiting
8. The Systemic Lens: Why Treatment-Resistant Depression Isn’t a Personal Failure
9. The Integration Sessions: Where the Real Work Happens
10. Frequently Asked Questions

She’d Tried Everything, and Nothing Had Touched It

Priya sat across from me at our intake session, her posture perfectly composed, her hands folded on the table. A 41-year-old physician and researcher in the Bay Area, she was the person other people called in a crisis. She solved problems for a living. She’d been doing that since she was seven years old, the oldest daughter of immigrants who’d sacrificed everything for her success.

She’d tried three antidepressants over five years. Two different therapists. A monthlong leave of absence that she mostly spent answering emails from her couch. A meditation app she abandoned after four days. Journaling. A weekend retreat. Acupuncture. The burnout didn’t budge. The depression didn’t lift. And the part that scared her most wasn’t the exhaustion — it was that she’d stopped being able to feel much of anything at all.

“I know every cognitive technique,” she told me. “I’ve read all the research. My brain just won’t let the information reach the part that actually needs to change.”

What Priya described is one of the defining frustrations of treatment-resistant depression: the knowing doesn’t reach the body. Talk therapy engages the prefrontal cortex — the thinking brain — but the alarm system lives deeper, in the amygdala and brainstem. Conventional antidepressants work on neurotransmitter levels, but they don’t touch the structural patterns. Ketamine-Assisted Psychotherapy offers a different point of entry entirely.

If you’ve exhausted conventional approaches and you’re still running on cortisol and sheer willpower, KAP may be worth a serious conversation with a qualified provider. Learn more about working with Annie to explore whether this is a fit for your situation.

What Is Ketamine-Assisted Psychotherapy?

DEFINITION
KETAMINE-ASSISTED PSYCHOTHERAPY (KAP)

Ketamine-Assisted Psychotherapy is a treatment protocol that combines a clinician-supervised, low-dose ketamine experience with structured psychotherapy sessions — both before and after the medicine session. Unlike ketamine infusion therapy alone, KAP uses the temporary neuroplasticity window ketamine creates to facilitate deeper psychological processing. The medicine opens the door. The therapy is what you do once you’re through it.

In plain terms: KAP isn’t about getting high or feeling better for a few hours. It’s a carefully structured clinical protocol that uses a brief window of altered brain chemistry to let psychotherapy actually land — instead of bouncing off the walls you’ve spent a lifetime building.

KAP is not a first-line treatment. It’s specifically designed for people whose depression, complex trauma, or burnout has failed to respond adequately to conventional approaches — what clinicians call treatment-resistant presentations. This distinguishes it from the broader cultural conversation about psychedelics, which can sometimes collapse important clinical distinctions.

Ketamine itself has been FDA-approved as an anesthetic since the 1970s and is legally used off-label for depression by licensed medical providers. Esketamine (Spravato), a nasal-spray form of ketamine, received direct FDA approval specifically for treatment-resistant depression in 2019. The KAP protocol — ketamine plus structured psychotherapy — goes a step further by embedding the medicine experience within a therapeutic relationship that can help you actually use the neurological opening it creates.

The psychotherapy component is what makes KAP meaningfully different from simply receiving infusions. Your therapist guides the preparation work, supports you during the medicine session, and — critically — facilitates the integration sessions afterward where insights become lasting change. Without those integration sessions, the neuroplasticity window opens and closes without being fully used. Understanding your nervous system is foundational to making sense of why that integration matters so much.

Protocols vary by provider and by the individual’s needs, but a typical course involves two to six medicine sessions, each preceded by preparation sessions and followed by integration sessions. The full arc generally spans several months. Some people do maintenance sessions afterward; many don’t require them once the initial work has taken hold.

The Neuroscience: What Ketamine Actually Does in the Brain

DEFINITION
DEFAULT MODE NETWORK (DMN)

The default mode network is the brain’s background-noise system — the circuit that generates self-referential thought, rumination, and the repetitive stories you tell yourself about who you are and what you deserve. In depression, anxiety, and burnout, the DMN becomes hyperactive. It replays failures, predicts catastrophe, and keeps you locked in loops that conscious reasoning alone can’t interrupt. Ketamine temporarily quiets the DMN, creating a brief but significant window in which new neural pathways can form more easily.

In plain terms: The DMN is the part of your brain that won’t shut up at 2 a.m. It’s the loop that replays every mistake, every insufficiency, every should-have-done-differently. Ketamine doesn’t just turn down the volume on that loop — it creates a moment of genuine quiet in which your brain can start writing new patterns instead of reinforcing the old ones.

Ketamine works primarily by blocking NMDA receptors and triggering a rapid increase in glutamate, which in turn stimulates the release of BDNF (brain-derived neurotrophic factor) — a protein that promotes neuroplasticity, the brain’s ability to form new connections. The clinical effect is both immediate and, with integration, lasting: not just an hour of relief but a structural loosening of the patterns that have kept you stuck.

James W. Murrough, MD, PhD, Professor of Psychiatry and Neuroscience and Director of the Depression and Anxiety Center for Discovery and Treatment at the Icahn School of Medicine at Mount Sinai, has conducted some of the most rigorous clinical research on ketamine for treatment-resistant depression. In his landmark 2013 randomized controlled trial published in The American Journal of Psychiatry, Murrough and colleagues demonstrated meaningful reductions in depressive symptoms within 24 hours of ketamine administration in patients who had failed multiple prior treatment attempts — a finding that reshaped how psychiatry understood what was even possible in treatment-resistant cases.

Robin Carhart-Harris, PhD, Ralph Metzner Distinguished Professor of Neurology and Psychiatry at the University of California San Francisco and one of the world’s leading researchers in psychedelic-assisted therapy, has described the mechanism this way: psychoactive substances like ketamine temporarily increase the brain’s plasticity, effectively creating a period of heightened openness in which therapeutic interventions can have outsized impact. The medicine alone isn’t the treatment. The medicine plus skilled psychotherapy is the treatment.

“Psychedelics may work not just by changing brain chemistry, but by providing a window of heightened plasticity during which the right psychological intervention can produce lasting change — a window that closes again if not used well.”

ROBIN CARHART-HARRIS, PhD, Ralph Metzner Distinguished Professor of Neurology and Psychiatry, University of California San Francisco

Simultaneously, ketamine quiets the default mode network — the mental loop generator responsible for rumination, self-criticism, and that exhausting inner monologue that replays every mistake. For driven women who’ve been running that loop for decades, even a brief interruption feels startling. And liberating. The brain’s old, well-worn grooves suddenly seem less inevitable.

This is distinct from what happens with conventional antidepressants. SSRIs and SNRIs work gradually on serotonin and norepinephrine systems, often taking four to six weeks to show effects and frequently producing a blunting of emotional range rather than genuine restoration. Ketamine works on an entirely different neurotransmitter system — glutamate — and its effects can appear within hours. This rapid mechanism is particularly important for people in severe or treatment-resistant states where waiting four to six weeks for a medication to work isn’t a safe or sustainable option.

It’s worth noting what ketamine doesn’t do: it doesn’t resolve the underlying psychological and relational wounds that often drive treatment-resistant depression. That’s what the therapy component is for. The neuroplasticity window ketamine creates is not a cure — it’s an opening. And like all openings, what you do with it determines whether it leads anywhere. This is why trauma-informed approaches like EMDR are particularly powerful in the integration phase: the window of increased plasticity makes previously defended material more accessible.

How Treatment-Resistant Depression Shows Up in Driven Women

When Priya first described her experience, she used a phrase I hear frequently from driven, ambitious women: “I know I should feel grateful. I have everything I worked for. I just feel nothing.”

Treatment-resistant depression in driven women rarely looks like a clinical textbook case. It doesn’t look like lying in bed unable to function. More often it looks like performing at 80% capacity while running on empty — still meeting every deadline, still showing up for everyone else, still presenting competence to the world, but privately feeling hollow, disconnected, and incapable of the joy that used to come naturally. The external markers of success remain fully intact while the internal experience quietly drains away.

This presentation makes it easy for driven women to minimize and delay. If you’re still producing, still managing, still showing up — are you really that bad off? The answer, clinically speaking, is sometimes yes. The gap between outer performance and inner experience is itself a symptom. And the longer it persists without intervention, the wider that gap tends to grow.

Free Relational Trauma Quiz

Do you come from a relational trauma background?

Most people don't recognize the signs -- they just know something feels off beneath the surface. Take Annie's free 30-question assessment.

5 minutes · Instant results · 23,000+ have taken it

Take the Free Quiz

What often underlies this pattern is a combination of factors: a nervous system that learned early to equate safety with productivity; complex trauma history that keeps the alarm system chronically activated; and a set of deeply internalized beliefs — I am only safe if I am producing, I cannot rest until everything is done, my value equals my output — that no amount of cognitive reframing seems to reach. These aren’t just thoughts. They’re neural patterns, laid down over years of experience, reinforced by a culture that rewards overperformance and pathologizes rest.

The definition of treatment-resistant depression in clinical settings generally refers to depression that has failed to respond adequately to at least two different antidepressant trials at adequate doses for adequate durations. But many of the women I work with have a more functional definition: they’ve tried the things that were supposed to work, and they haven’t worked. The mechanism may vary; the lived experience of stuck is the same.

For Priya, the stuckness had become its own kind of prison. She understood the neuroscience of burnout — she was, after all, a physician. She understood what was happening. She just couldn’t make herself feel differently by understanding it. That gap — between knowing and feeling — is exactly where KAP can operate. Trauma-informed coaching can be a powerful complement, especially in building the external structure that supports integration work.

KAP and Relational Trauma: The Connection Most People Miss

Here’s what the public conversation about KAP often misses: for many women, the depression that hasn’t responded to conventional treatment isn’t primarily a serotonin problem. It’s a trauma problem. The attachment wounds and relational injuries that happened early in life create a nervous system that stays in chronic survival mode — and chronic survival mode is neurologically incompatible with healing.

When your nervous system learned early that the world was unpredictable and that people weren’t reliably safe, it built an alarm system calibrated for that world. Antidepressants don’t recalibrate that alarm system. Talk therapy reaches it more directly, but when the defenses are high — when decades of intellectualization and performance have built a very good wall between the thinking brain and the feeling brain — even skilled therapy can struggle to penetrate.

This is where KAP becomes particularly significant for women with relational trauma histories. The dissociative quality of the ketamine experience — the sense of gentle detachment from ordinary reality — creates a state in which the usual defenses are temporarily lowered. Material that would normally be too threatening to approach becomes more accessible. The inner child who learned not to need, not to feel, not to want — she shows up. And the integration work with a skilled therapist helps you meet her with something new.

Elena, a 38-year-old attorney and mother of two who had grown up with a chronically depressed mother and an emotionally unavailable father, came to KAP after years of therapy that she described as “very helpful intellectually, but not reaching whatever’s underneath the knowing.” (Name and details have been changed for confidentiality.) She’d been on two different SSRIs over a decade. She was functional, competent, and privately convinced that genuine joy was just not available to her — that some people got to feel it and she didn’t.

What surfaced in Elena’s first medicine session wasn’t dramatic or visual. It was quieter than that. The internal monologue that usually ran constantly — the critic, the scorekeeper, the voice that catalogued everything she hadn’t done well enough — went silent. And in that silence, she said, she could feel something she hadn’t felt in years: her own presence. Not her performance of herself. Her actual self.

The integration sessions that followed were where the real work happened. We explored what it meant that the critic’s voice wasn’t actually her. That the voice was learned — absorbed from a household where she’d been required to be small and capable and undemanding simultaneously. That the silence she’d felt in the medicine session was available to her, not as an altered state, but as a reclaimed part of who she was before she learned to disappear. Inner child work became particularly generative in those integration months — the ketamine-opened window made it possible in a way years of standard therapy hadn’t.

The Both/And Reframe: Surrendering Control to Reclaim Yourself

There’s a paradox at the heart of KAP that I think deserves naming directly, because it trips up a lot of the driven, ambitious women I work with: this treatment requires surrendering control.

Not forever. Not entirely. But in the medicine session, you cannot intellectualize your way through what surfaces. You cannot manage the experience into something safer. You have to let the process work on you rather than working the process. For women who have built their entire sense of safety around competence and control — and whose trauma histories often made control feel like survival — this is not a small ask.

And it’s also the very thing that makes KAP work.

This is the both/and of KAP: you can be someone who thrives on competence AND you can be someone who needs to let go of that competence temporarily to heal. These aren’t contradictory. They’re complementary. The control that protected you when the world wasn’t safe doesn’t need to be the only tool you have now that you’re building a safer life. You can keep your capability AND develop a relationship with surrender. Both are available. Both are yours.

Priya came back to our session two weeks after her first medicine session and said something I’ve since heard in different forms from many women who go through this process: “I realized in there that I’ve never actually let anyone help me. Not really. I’ve accepted help in a way that I control — where I decide what kind of help I need and when. But actually letting the process work on me without managing it? I’ve never done that. And it turns out that’s the entire problem.”

The both/and extends into how we understand ambition itself. You can be driven and ambitious AND deeply, clinically burned out. You can want to heal AND be terrified of who you’ll be without the survival mode that has always kept you moving. You can be skeptical of a treatment that involves altered states AND genuinely curious about whether it might be the thing that finally works. None of these pairs cancel each other out. They exist together. And holding them together — instead of collapsing into one side — is itself part of the healing.

What I see consistently in my work with clients who go through KAP is that the medicine session often provides an experiential demonstration of something they’ve been told cognitively but haven’t been able to feel: that they are okay beneath all the striving. That there’s a self there that isn’t contingent on performance. And that glimpse — however brief — becomes something they can orient toward in the integration work that follows. If you’re wondering whether this kind of work might be right for you, the quiz can help you identify the core patterns that might be driving your treatment resistance.

The Hidden Cost of Waiting

Treatment-resistant depression carries real costs — and not just the ones that feel clinical. There’s the cost of showing up to your relationships from a place of emotional depletion rather than genuine presence. There’s the cost of the career decisions you don’t make because you can’t access your own desire clearly enough to know what you actually want. There’s the cost of the friendships that quietly thin out because maintaining them takes more energy than you have.

And there’s the specific cost that many driven women don’t talk about: the cost to their sense of self. When you’ve defined your worth through your capacity to function and your capacity to function becomes compromised, the identity-level reckoning is brutal. It’s not just that you feel bad. It’s that you stop recognizing yourself.

The research on untreated or inadequately treated depression is sobering. Chronic depression changes brain structure over time — hippocampal volume decreases with prolonged depressive episodes, affecting memory and emotional regulation. The longer treatment resistance continues without intervention, the more entrenched the neural patterns become. This isn’t meant to frighten anyone into a decision they’re not ready for. It’s meant to normalize urgency — to name that continuing to try approaches that aren’t working, out of caution or skepticism about something new, has its own risks.

KAP isn’t appropriate for everyone, and it shouldn’t be pursued casually. But for women who have genuinely exhausted conventional approaches — not just tried them once or twice, but given them a real chance and found them insufficient — the cost of not exploring this option deserves the same scrutiny as the cost of trying it.

Healing is possible. It isn’t guaranteed, and it isn’t linear, and it’s not identical for everyone. But the fact of treatment resistance isn’t evidence that healing is off the table. It’s evidence that you haven’t yet found the right point of entry. Fixing the Foundations, Annie’s signature course on relational trauma recovery, is one of the tools many women use in parallel with or following KAP to do the sustained integration work that creates lasting change.

The Systemic Lens: Why Treatment-Resistant Depression Isn’t a Personal Failure

When a woman tries multiple antidepressants and multiple therapy modalities and doesn’t get better, the cultural narrative tends to locate the problem inside her. She didn’t try hard enough. She didn’t really commit. She’s resistant in a psychological sense, not just a clinical one. This narrative is false, and it’s harmful, and it’s worth naming directly.

Treatment resistance is, in part, a systems problem. The standard of care for depression was built largely on research conducted predominantly on male participants, calibrated for presentations that show up differently in women, and designed within a healthcare system that gives physicians seven to fifteen minutes per appointment to assess something as complex as psychiatric treatment response. The miracle isn’t that some women don’t respond to first-line treatments. The miracle is that some do.

There’s also the systemic context of what creates treatment-resistant depression in the first place. Chronic stress, relational trauma, intergenerational trauma patterns, economic precarity, caregiving load that falls disproportionately on women, racial and cultural marginalization — these aren’t just contributing factors. For many women, they’re the primary drivers of a nervous system that stays in chronic survival mode. And a nervous system in chronic survival mode is neurobiologically resistant to healing — not because of anything the individual is doing wrong, but because of what the system keeps requiring of her.

KAP doesn’t solve systemic problems. A medicine session doesn’t change the caregiving load or the workplace culture or the family system that keeps replicating old wounds. What it can do is create enough of an internal shift — enough neurological loosening — that a woman becomes better resourced to make different choices within those systems, to set different limits, to see the patterns she’s been too depleted to see clearly.

The systemic lens also matters for how we think about access. KAP is expensive. It’s not widely covered by insurance. The psychotherapy component is often billable, but the ketamine administration itself frequently isn’t. This means that a genuinely promising treatment for a genuinely disabling condition remains inaccessible to many of the women who need it most. That’s a system problem, not a personal one. And naming it matters — both for the women who do have access and are weighing whether to use it, and for those who don’t and deserve to know that their inability to access this treatment isn’t a reflection of what they deserve.

What I see consistently in my work is that the women most likely to dismiss KAP as “not for them” are often the women who most internalize the cultural messaging that their suffering is a personal management problem rather than a clinical one. They’re the ones who’ve tried the hardest and received the least credit for how hard they’ve been trying. Childhood emotional neglect patterns and intergenerational trauma often run directly under treatment-resistant presentations — invisible to the standard clinical gaze but central to understanding why conventional treatments don’t reach them.

The Integration Sessions: Where the Real Work Happens

Here’s the part most people miss when they first learn about KAP: the ketamine session is not the treatment. It’s the opening. The treatment is what you do with the opening — and that happens in the integration sessions that come after.

Integration refers to the psychotherapy sessions in the days and weeks following a medicine session. The neuroplasticity window that ketamine creates doesn’t stay open indefinitely. It closes — typically within a few days to a couple of weeks, depending on the individual and the protocol. What happens in that window determines whether the medicine experience becomes a source of lasting change or simply a vivid memory.

For driven women, integration often involves confronting the core beliefs that have been running the show: I am only safe if I am producing. I cannot rest until everything is done. My value equals my output. These beliefs don’t announce themselves as beliefs — they feel like facts, like the fundamental structure of reality. The ketamine-created window makes them more accessible and less defended, which means the therapy can actually land rather than bouncing off decades of intellectualization and performance.

Good integration work is active, relational, and ongoing. It’s not processing a single insight and moving on. It’s the slow, careful work of taking what surfaced in the medicine session and weaving it into everyday patterns — into how you respond when your partner disappoints you, how you handle the moments when your inner critic ramps up, how you relate to rest, how you make decisions about your time. This is the work that makes the neuroplasticity window actually matter.

KAP integrates particularly well with EMDR therapy, somatic approaches, and inner child work. These modalities work on the body-held, pre-verbal material that talk therapy alone struggles to reach — and the increased openness the ketamine window creates makes them more effective than they’d be otherwise. Your treatment team should coordinate carefully to make the most of this overlap.

For Priya, the integration work over the months following her KAP course became some of the most meaningful therapy she’d ever done — not because the insights were new, but because they finally reached somewhere. “I’d been told a hundred times that my worth isn’t contingent on my productivity,” she told me. “This time I actually felt it as true instead of understanding it as true. That’s a completely different thing.”

If you’re curious about whether KAP might be appropriate for your situation, the first step is a thorough assessment with a qualified provider. Reach out here to start that conversation — and to explore what your path forward might look like, whether or not it includes KAP.

You’ve been trying so hard for so long. You deserve an approach that actually meets you where you are — not where the standard protocol assumes you’ll be. Treatment resistance isn’t the end of the road. It’s information about which road you haven’t tried yet. And there are roads left.